Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

NCT01581398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

770

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ypeginterferon alfa-2b
DRUG: Pegasys
DRUG: Ypeginterferon alfa-2b
DRUG: Pegasys

Sponsor

Xiamen Amoytop Biotech Co., Ltd.